Register entry

Xellia Pharmaceuticals ApS

Data as of · How to read this entry

Registered sites
3
Active NDC listings
50
Labeller names
3
Live patents
0
Countries
3
Base
Denmark
Authorisation

Registered operations

Analytical testing3Active ingredient (API) manufacture3Labelling1Finished drug manufacture1Packaging1
Sites

Registered establishments

3
EstablishmentAddressRegistered forFEI / DUNS
Xellia (Taizhou) Pharmaceuticals Co., Ltd.Registrant: Xellia Pharmaceuticals ApS108 Binhai Road, Jiaojiang District, Jiaojiang Dist., Taizhou, Zhejiang 318000, China (CHN)Analytical testing, Active ingredient (API) manufacture3007422723529171201
Xellia Pharmaceuticals ApSDalslandsgade 11, Copenhagen S, Region Hovedstaden 2300, Denmark (DNK)Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging3002806860305814345
Xellia Pharmaceuticals Ltd.Registrant: Xellia Pharmaceuticals ApSSz�ll�s utca 1-3, Budapest, Budapest H-1107, Hungary (HUN)Analytical testing, Active ingredient (API) manufacture3002808179401172630
Catalogue

Drug listings by form and route

50

50 active NDC listings: 34 human prescription drug, 16 bulk ingredient. By marketing category: ANDA 23, BULK INGREDIENT 16, NDA 11.

Dosage formNDCs
injection, solution16
powder16
injection, powder, lyophilized, for solution7
injection6
injection, powder, for solution4
solution1
RouteNDCs
intravenous24
perineural8
epidural6
intracaudal6
intramuscular3
intrathecal1
ophthalmic1
subcutaneous1
Labeller name on the listingNDCs
xellia pharmaceuticals usa llc34
xellia pharmaceuticals aps15
xellia pharmaceuticals ltd1
Catalogue

Marketed products

50
BrandGeneric nameForm / routeNDC
AcetylcysteineAcetylcysteineinjection, solution, intravenous70594-111ANDA
-Amphotericin Bpowder45932-0008BULK INGREDIENT
BUPIVACAINE HClBupivacaine hydrochlorideinjection, solution, epidural, intracaudal, perineural70594-115ANDA
-Bacitracin Zincpowder45932-0022BULK INGREDIENT
Bupivacaine HClBupivacaine hydrochlorideinjection, solution, epidural, intracaudal, perineural70594-114ANDA
Bupivacaine HClBupivacaine Hydrochlorideinjection, solution, perineural70594-116ANDA
Bupivacaine HClBupivacaine hydrochlorideinjection, solution, epidural, intracaudal, perineural70594-117ANDA
Bupivacaine HClBupivacaine hydrochlorideinjection, solution, epidural, intracaudal, perineural70594-118ANDA
Bupivacaine HClBupivacaine Hydrochlorideinjection, solution, perineural70594-119ANDA
Bupivacaine HClBupivacaine hydrochlorideinjection, solution, epidural, intracaudal, perineural70594-120ANDA
Bupivacine HClBupivacaine hydrochlorideinjection, solution, epidural, intracaudal, perineural70594-121ANDA
-COLISTIMETHATE SODIUMpowder45932-0053BULK INGREDIENT
Carboprost Tromethaminecarboprost tromethaminesolution, intramuscular70594-112ANDA
ColistimethateColistimethate Sodiuminjection, powder, for solution, intramuscular, intravenous70594-023ANDA
-Colistimethate sodiumpowder45932-0015BULK INGREDIENT
-Colistimethate sodiumpowder45932-0016BULK INGREDIENT
-Colistin Sulfatepowder45932-0003BULK INGREDIENT
DaptomycinDaptomycininjection, powder, lyophilized, for solution, intravenous70594-034ANDA
DaptomycinDaptomycininjection, powder, lyophilized, for solution, intravenous70594-053NDA
Daptomycindaptomycininjection, powder, lyophilized, for solution, intravenous70594-060NDA
Daptomycindaptomycininjection, powder, lyophilized, for solution, intravenous70594-066NDA
-Gramicidinpowder61046-0003BULK INGREDIENT
MEROPENEMMEROPENEMinjection, powder, for solution, intravenous70594-075ANDA
MEROPENEMMEROPENEMinjection, powder, for solution, intravenous70594-076ANDA
Neostigmine MethylsulfateNeostigmine Methylsulfateinjection, intravenous70594-069ANDA
Neostigmine MethylsulfateNeostigmine Methylsulfateinjection, intravenous70594-072ANDA
Phenylephrine HydrochloridePHENYLEPHRINE HYDROCHLORIDEinjection, intravenous70594-063ANDA
Phenylephrine HydrochloridePHENYLEPHRINE HYDROCHLORIDEinjection, intravenous70594-064ANDA
Phenylephrine HydrochloridePHENYLEPHRINE HYDROCHLORIDEinjection, intravenous70594-065ANDA
Polymyxin BPolymyxin B Sulfateinjection, powder, for solution, intramuscular, intrathecal, intravenous, ophthalmic70594-049ANDA
-Polymyxin B Sulfatepowder45932-0001BULK INGREDIENT
-Polymyxin B Sulfatepowder45932-0002BULK INGREDIENT
-Polymyxin B Sulfatepowder45932-0017BULK INGREDIENT
-Polymyxin B Sulfatepowder45932-0018BULK INGREDIENT
SumatriptanSUMATRIPTAN SUCCINATEinjection, subcutaneous70594-068ANDA
-Tobramycin sulfatepowder45932-0012BULK INGREDIENT
-Tobramycin sulfatepowder45932-0014BULK INGREDIENT
-Vancomycinpowder45932-0050BULK INGREDIENT
VancomycinVancomycininjection, solution, intravenous70594-041NDA
VancomycinVancomycininjection, solution, intravenous70594-042NDA
VancomycinVancomycininjection, solution, intravenous70594-043NDA
VancomycinVancomycininjection, solution, intravenous70594-044NDA
VancomycinVancomycininjection, solution, intravenous70594-056NDA
VancomycinVancomycininjection, solution, intravenous70594-057NDA
VancomycinVancomycininjection, solution, intravenous70594-058NDA
-Vancomycin Hydrochloridepowder45932-0009BULK INGREDIENT
-Vancomycin Hydrochloridepowder45932-0010BULK INGREDIENT
Vancomycin Hydrochloridevancomycin hydrochlorideinjection, powder, lyophilized, for solution, intravenous70594-122ANDA
Vancomycin Hydrochloridevancomycin hydrochlorideinjection, powder, lyophilized, for solution, intravenous70594-123ANDA
VoriconazoleVoriconazoleinjection, powder, lyophilized, for solution, intravenous70594-067NDA
Neighbours

Registered in the same town

12
Compare

Comparable companies in Denmark

Enquiry

Common questions

Is Xellia Pharmaceuticals ApS FDA approved?
Xellia Pharmaceuticals ApS holds 3 FDA-registered establishments across 3 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Xellia Pharmaceuticals ApS's drugs manufactured?
At registered sites in China, Denmark, Hungary. The FDA register lists Taizhou; Copenhagen S; Budapest. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging.
What drugs does Xellia Pharmaceuticals ApS make?
50 products are listed under Xellia Pharmaceuticals ApS in the openFDA NDC Directory, most often as injection, solution; powder; injection, powder, lyophilized, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.